Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
6.13E-29
|
-1.01E+00
|
-1.69E+00 |
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
2.74E-07
|
-2.63E-01
|
-8.94E-01 |
Asthma
|
CA23 |
Nasal and bronchial airway |
1.29E-01
|
-8.09E-02
|
-2.25E-01 |
Behcet's disease
|
4A62 |
Peripheral blood |
6.82E-01
|
3.39E-02
|
1.30E-01 |
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
8.02E-02
|
-1.52E-02
|
-4.02E-02 |
Bladder cancer
|
2C94 |
Bladder tissue |
4.64E-02
|
-1.39E-01
|
-6.19E-01 |
Breast cancer
|
2C60-2C6Z |
Breast tissue |
1.03E-20
|
3.37E-01
|
5.49E-01 |
Colon cancer
|
2B90 |
Colon tissue |
9.06E-11
|
-1.70E-01
|
-6.00E-01 |
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
2.45E-01
|
8.57E-02
|
2.56E-01 |
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
3.63E-01
|
7.76E-02
|
3.56E-01 |
Gastric cancer
|
2B72 |
Gastric tissue |
5.93E-01
|
-4.19E-01
|
-8.96E-01 |
Glioblastopma
|
2A00.00 |
Nervous tissue |
7.33E-151
|
-9.58E-01
|
-2.24E+00 |
Head and neck cancer
|
2D42 |
Head and neck tissue |
1.25E-11
|
-4.26E-01
|
-8.44E-01 |
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
9.48E-01
|
2.23E-02
|
4.63E-02 |
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
7.62E-01
|
-1.72E-02
|
-5.53E-02 |
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
2.87E-01
|
-6.24E-02
|
-3.35E-01 |
Ischemic stroke
|
8B11 |
Peripheral blood |
2.01E-01
|
1.03E-01
|
7.03E-01 |
Liver cancer
|
2C12.0 |
Liver tissue |
3.70E-11
|
-7.63E-01
|
-1.31E+00 |
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
7.70E-05
|
-1.47E+00
|
-2.47E+00 |
Lung cancer
|
2C25 |
Lung tissue |
9.07E-17
|
-2.58E-01
|
-1.12E+00 |
Lupus erythematosus
|
4A40 |
Whole blood |
2.15E-10
|
-6.03E-01
|
-9.10E-01 |
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
8.59E-01
|
2.42E-02
|
6.40E-02 |
Multiple myeloma
|
2A83.1 |
Bone marrow |
6.05E-05
|
8.18E-01
|
2.75E+00 |
Multiple myeloma
|
2A83.1 |
Peripheral blood |
5.76E-01
|
-1.56E-01
|
-1.27E+00 |
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
2.48E-01
|
-1.11E-01
|
-3.14E-01 |
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
7.41E-02
|
2.42E-01
|
5.53E-01 |
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
5.14E-01
|
-3.80E-02
|
-3.03E-02 |
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
4.31E-01
|
-1.44E-01
|
-4.51E-01 |
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
2.40E-01
|
5.11E-02
|
1.85E-01 |
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
3.61E-02
|
3.33E-01
|
2.02E+00 |
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
7.76E-01
|
-1.16E-01
|
-1.57E-01 |
Oral cancer
|
2B6E |
Oral tissue |
2.12E-06
|
-4.86E-01
|
-9.79E-01 |
Ovarian cancer
|
2C73 |
Ovarian tissue |
1.61E-03
|
6.02E-01
|
1.58E+00 |
Pancreatic cancer
|
2C10 |
Pancreas |
1.13E-02
|
-2.11E-01
|
-6.98E-01 |
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
2.19E-01
|
3.90E-02
|
1.06E-01 |
Pituitary cancer
|
2D12 |
Pituitary tissue |
8.66E-03
|
2.59E-01
|
9.00E-01 |
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
2.40E-01
|
2.29E-01
|
7.96E-01 |
Pompe disease
|
5C51.3 |
Biceps muscle |
2.74E-01
|
2.13E-01
|
8.58E-01 |
Prostate cancer
|
2C82 |
Prostate |
6.34E-05
|
8.81E-01
|
1.45E+00 |
Psoriasis
|
EA90 |
Skin |
1.09E-05
|
1.39E-01
|
4.84E-01 |
Rectal cancer
|
2B92 |
Rectal colon tissue |
9.16E-06
|
-3.92E-01
|
-3.83E+00 |
Renal cancer
|
2C90-2C91 |
Kidney |
8.52E-03
|
-6.65E-01
|
-1.13E+00 |
Retinoblastoma
|
2D02.2 |
Uvea |
2.06E-07
|
-9.23E-01
|
-5.18E+00 |
Schizophrenia
|
6A20 |
Prefrontal cortex |
6.00E-04
|
-1.87E-01
|
-3.38E-01 |
Schizophrenia
|
6A20 |
Superior temporal cortex |
3.69E-01
|
1.48E-02
|
5.91E-02 |
Scleroderma
|
4A42.Z |
Whole blood |
2.03E-02
|
-2.37E-01
|
-6.95E-01 |
Seizure
|
8A60-8A6Z |
Whole blood |
3.32E-01
|
-1.89E-01
|
-2.86E-01 |
Sepsis with septic shock
|
1G41 |
Whole blood |
1.97E-20
|
-5.11E-01
|
-1.09E+00 |
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
1.36E-02
|
1.64E-01
|
7.33E-01 |
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
3.05E-01
|
6.09E-02
|
7.24E-01 |
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
2.88E-04
|
-4.78E-01
|
-3.63E+00 |
Skin cancer
|
2C30-2C3Z |
Skin |
9.30E-05
|
2.10E-01
|
5.30E-01 |
Thrombocythemia
|
3B63 |
Whole blood |
3.39E-01
|
1.14E-01
|
3.24E-01 |
Thrombocytopenia
|
3B64 |
Whole blood |
4.83E-01
|
2.64E-01
|
1.93E-01 |
Thyroid cancer
|
2D10 |
Thyroid |
5.74E-02
|
6.03E-02
|
2.78E-01 |
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
2.78E-03
|
-3.94E-01
|
-1.37E+00 |
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
9.95E-04
|
-8.33E-01
|
-4.66E+00 |
Type 2 diabetes
|
5A11 |
Liver tissue |
4.74E-02
|
-2.56E-01
|
-1.12E+00 |
Ureter cancer
|
2C92 |
Urothelium |
4.40E-01
|
1.89E-02
|
1.02E-01 |
Uterine cancer
|
2C78 |
Endometrium tissue |
2.32E-06
|
-1.98E-01
|
-3.53E-01 |
Vitiligo
|
ED63.0 |
Skin |
3.27E-01
|
5.94E-02
|
5.37E-01 |
------------------------------------------------------------------------------------ |
|
|
|
|
|